NCT04796064
Completed
Not Applicable
Comparative Effectiveness Study of Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 Sarcopenia
ConditionsSarcopenia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sarcopenia
- Sponsor
- Cairo University
- Enrollment
- 76
- Locations
- 1
- Primary Endpoint
- Handgrip strength
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Sarcopenia is the major health concern and common consequence of COVID-19 in the ageing population. The objective of this study is to find and compare low and high-intensity aerobic training protocols on clinical and psychological effects in community-dwelling older men with post-COVID 19 Sarcopenia.
Investigators
Marwa Eid
assistant professor of physical therapy for surgery
Cairo University
Eligibility Criteria
Inclusion Criteria
- •Age range of 60 - 80 years with
- •A positive diagnosis of post-COVID-19 sarcopenia
Exclusion Criteria
- •Under medication
- •History of lower limb surgeries, fractures
- •Cardiac problems
- •Respiratory problems
- •Neurological problems
- •Systemic problems and any other contraindications for aerobic training
Outcomes
Primary Outcomes
Handgrip strength
Time Frame: 8 weeks
It is a simple and cost-effective test to measure the upper limb strength
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Integrated Physical Training With Protein Diet in Older Adults With Sarcopenia Symptoms.SarcopeniaNCT05224453Prince Sattam Bin Abdulaziz University76
Terminated
Not Applicable
Sarcopenia and Related Factors in Coronavirus Disease 2019 (COVID-19) Following Intensive CareSarcopeniaCovid19Intensive Care Unit Acquired WeaknessNCT05474157Koç University30
Unknown
Not Applicable
Sarcopenia Studies for the Elderly Population in TaiwanSarcopeniaNCT00174135National Taiwan University Hospital100
Not yet recruiting
Not Applicable
Feasibility of Proteomics in Chronic Lung Disease With SarcopeniaSarcopeniaChronic Lung DiseaseNCT06312774University College, London49
Unknown
Phase 3
Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 VirusCOVID - 19NCT04355052Sheba Medical Center250